Charles River Labs Intl buy JPMorgan Chase & Co.
Start price
20.12.23
/
50%
€211.90
Target price
20.12.24
€246.65
Performance (%)
-15.24%
End price
21.12.24
€179.60
Summary
This prediction ended on 21.12.24 with a price of €179.60. The prediction for Charles River Labs Intl disappointed with a performance of -15.24%. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Charles River Labs Intl | 9.719% | 9.719% | 40.173% |
| iShares Core DAX® | 2,99 % | 3,22 % | 4,27 % |
| iShares Nasdaq 100 | -1,58 % | -3,17 % | 24,75 % |
| iShares Nikkei 225® | -2,25 % | -9,92 % | 43,52 % |
| iShares S&P 500 | -0,01 % | 1,64 % | 20,97 % |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Charles River Labs Intl diskutieren
Charles River Laboratories International, Inc. (NYSE: CRL) had its price target raised by analysts at JPMorgan Chase & Co. from $210.00 to $270.00. They now have an "overweight" rating on the stock.
Ratings data for CRL provided by MarketBeat
In the thread Trading Charles River Labs Intl
Die von JPMorgan_Chase___Co_ gewählte maximale Laufzeit wurde überschritten
Stopped prediction by JPMorgan_Chase___Co_ for Charles River Labs Intl
Charles River Labs Intl
Start price
Target price
Perf. (%)
€227.80
15.02.24
15.02.24
€259.70
15.02.25
15.02.25
-36.02%
16.02.25
16.02.25
Charles River Labs Intl
Start price
Target price
Perf. (%)
€198.20
10.08.23
10.08.23
€227.00
10.08.24
10.08.24
-7.39%
11.08.24
11.08.24